Research on the movement of antidotes and toxic metabolites in the patients with acetaminophen poisoning
对乙酰氨基酚中毒患者解毒剂及毒性代谢物的迁移研究
基本信息
- 批准号:13671623
- 负责人:
- 金额:$ 1.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Acetaminophen is widely used as an analgesic and antipyretic drug instead of aspirin. As it is contained in most flu drugs that are on the market, it can easily be obtained. It is widely noticed that a relatively small dose of acetaminophen can cause a fatal hepatic darangement. Acetaminophen itself is not toxic, but its intermediate metabolite N-acetyl-p-benzoquinone imine (NAPQI) is known to be toxic. When reduced glutathion, an activated compound, is depleted, NAPQI irreversibly binds with various kinds of protein in the liver, and hence it is hepatotoxic.We investigated to detect the blood concentration of NAPQI with liquid chromatography! mass spectroscopy, and have gotten important findings. That is, asNAPQI promptly combines with activated-SH and is a highly unstable compound, it is impossible to detect it directly. However, we found that NAPQI covalently bond with GSH(GS-APAP) can relatively easily be detected by Liquid Chromatography /Mass Spectrogrphy (LCIMS). We also tried to detect the NAC (N-acetyl-cysteine) with LCIMS, and succeeded to detect the specific signal of mass spectrogram.When patients are admitted due to overdose of acetaminophen, its blood concentrations were determined on admission and after the treatment with antidote. However, the number of patients admitted with the overdose was too small, and all the patients were not severe enough to be treated with blood purification. Hence, we could not determine the changes in the blood concentrations of acetaminophen and its metabolite serially. We determined the blood concentrations of acetaminophen before and after intragastric administration of antidotes in a few patients.
对乙酰氨基酚被广泛用作止痛和解热药,以代替阿司匹林。由于它包含在市场上的大多数流感药物中,因此很容易获得。人们普遍注意到,相对小剂量的醋氨酚可引起致命的肝损害。对乙酰氨基酚本身无毒,但其中间代谢物N-乙酰基-对苯醌亚胺(NAPQI)已知有毒。NAPQI是一种活性化合物,当还原型谷胱甘肽耗尽时,NAPQI与肝脏中的各种蛋白质不可逆地结合,因此具有肝毒性。质谱,并得到了重要的发现。也就是说,由于NAPQI迅速与活化的SH结合,并且是一种高度不稳定的化合物,因此不可能直接检测到它。然而,我们发现NAPQI与GSH共价键合(GS-APAP)可以相对容易地通过液相色谱/质谱(LCIMS)检测。我们还尝试用LCIMS检测NAC(N-乙酰半胱氨酸),成功地检测到了质谱图的特异性信号,并对因对乙酰氨基酚过量而入院的患者,在入院时和治疗后测定其血药浓度。然而,因药物过量而入院的患者数量太少,而且所有患者的病情都不严重,不足以接受血液净化治疗。因此,我们无法连续测定对乙酰氨基酚及其代谢物的血药浓度变化。我们测定了少数患者灌胃给药解毒剂前后对乙酰氨基酚的血药浓度。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Toshio Nakatani, Yasuhiro Yamamoto: "Acute poisoning"Today's Therapy. 46. 1129-1154 (2004)
中谷俊夫、山本泰宏:《急性中毒》今日疗法。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
堀 寧, 岩崎 泰昌, 黒木由美子, 小宮山豊, 中谷壽男, 他: "アセトアミノフェン"中毒研究. 15(4). 385-390 (2002)
N. Hori、Yasumasa Iwasaki、Yumiko Kuroki、Yutaka Komiyama、Hisao Nakatani 等人:“对乙酰氨基酚”成瘾研究 15(4) 385-390 (2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
中谷壽男, 山本保博: "急性中毒"今日の治療指針. 45. 1099-1124 (2003)
Hisao Nakatani、Yasuhiro Yamamoto:《急性中毒》当今治疗指南 45. 1099-1124 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Toshio Nakatani, Yasuhiro Yamamoto: "Acute poisoning"Today's Therapy. 44. 1041-1064 (2002)
中谷俊夫、山本泰宏:《急性中毒》今日疗法。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
中谷壽男, 新谷 裕, 原 克子, 小宮山豊, 高橋伯夫: "急性中毒における高度救命救急センターの役割"日本職業・災害医学会. 50(5). 331-334 (2002)
Hisao Nakatani、Yutaka Shintani、Katsuko Hara、Yutaka Komiyama 和 Hakuo Takahashi:“高级重症监护中心在急性中毒中的作用”日本职业与灾害医学学会 50(5) (2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIRIDOSHI Masaya其他文献
KIRIDOSHI Masaya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
抗酸化能を高めたN-acetylcysteineによる老視と白内障抑制機構の解明
阐明具有增强抗氧化能力的N-乙酰半胱氨酸抑制老花眼和白内障的机制
- 批准号:
23K15945 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
- 批准号:
10758985 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
- 批准号:
10619173 - 财政年份:2022
- 资助金额:
$ 1.54万 - 项目类别:
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
- 批准号:
10517287 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
N-乙酰半胱氨酸治疗酒精使用障碍的随机对照试验
- 批准号:
nhmrc : 2001375 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
Clinical Trials and Cohort Studies Grants
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
- 批准号:
10368472 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
- 批准号:
10221760 - 财政年份:2020
- 资助金额:
$ 1.54万 - 项目类别:
N-acetylcysteineの骨治癒促進効果の検討
N-乙酰半胱氨酸促进骨愈合作用的考察
- 批准号:
20H01118 - 财政年份:2020
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Encouragement of Scientists